Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyRegulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasivenessTargeting the insulin growth factor receptor 1Glucose metabolism in gastric cancer: The cutting-edgeComparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric CancerThe colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information.Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma.Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachCarcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.Targeting the stromal fibroblasts: a novel approach to melanoma therapy.Gene therapy for gastric cancer: is it promising?Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancerProtein profiling of alpha-fetoprotein producing gastric adenocarcinoma.Marginal effects of glucose, insulin and insulin-like growth factor on chemotherapy response in endothelial and colorectal cancer cells.Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models.Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling.IGF-IR and its inhibitors in gastrointestinal carcinomas (Review).The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers.Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation.The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.Genetic blockade of insulin-like growth factor-1 receptor via recombinant adenovirus in lung cancer can be enhanced by the histone deacetylase inhibitor, vorinostat.Inhibition of IGF-IR increases chemosensitivity in human colorectal cancer cells through MRP-2 promoter suppression.Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.Inhibition of IGF receptor signaling and hepatoma cell growth by an antibody to ligand oligopeptide of receptor.A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers.Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.
P2860
Q22299231-7B26620F-5F00-4E68-AA79-3E1E2EEB7722Q24301119-BB000DCC-2E7E-4049-B9D0-03025CE939B9Q24633750-8030647E-1A52-4EC9-99ED-CF53DD94F269Q26766098-B35763BD-C1E8-4E3C-86BE-E045D612E5E2Q26771422-4827778D-B2A2-4D75-939A-9876C927914FQ33776217-6C54C6D1-4D6F-4CA0-B695-FD875A50C733Q33879899-C0513BDE-7FA5-45C2-821D-5B2F14A562E4Q33925323-12D32174-6ECD-4FA1-9630-D64ECCE538EEQ36120729-F100A9B8-DE56-4815-9FC9-D23CB3EE5D97Q36334912-356D9981-EDAF-4A68-96C1-449C1C14ABF4Q36401504-ADC42A3D-2E00-4F53-B573-EEC39E64FB45Q36450457-918AB731-C942-4AE4-AD27-32DBB217F206Q37317578-428655DC-32E3-483C-BDC7-33C3A7D1E659Q37437967-46426B78-BE4B-4F33-AE08-AE7C1842DCD2Q37565014-43C43B89-C74F-4259-AB3B-8177480F884CQ37588787-EE856012-40FE-4FD7-8293-10AC1AC63FDCQ38042423-F7806523-B370-4B7C-8BA6-A4C8F9879BAFQ38472348-357F99FF-5D41-440C-9573-7F786AB01E4CQ38756848-639C8FDD-A5C6-4A55-988D-36329105C024Q38764039-AC885938-2AD0-42FF-AE47-EE3DE4362680Q39096931-2AA01EC7-84A2-4ACB-9172-FB19DBE48AEDQ39193890-D5A8728D-0A2D-4734-9EB6-9ED1AAE811F0Q39406723-A9663E31-B984-4DB3-B40A-9739392767A4Q39449572-ED88B365-D46F-4137-9D08-A870365F1A69Q39603245-ED30AD18-A4C6-4FA0-B7B7-5B41B70DED36Q39998569-7F44927A-87CD-4372-AFD6-33E991DFA22BQ42540944-CB3C7FE6-336B-4412-881E-43E1FC5BB84BQ43925665-8B3AACFA-1792-4ABF-8466-3140A90B5A65
P2860
Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Insulin-like growth factor I r ...... man gastric cancer xenografts.
@ast
Insulin-like growth factor I r ...... man gastric cancer xenografts.
@en
type
label
Insulin-like growth factor I r ...... man gastric cancer xenografts.
@ast
Insulin-like growth factor I r ...... man gastric cancer xenografts.
@en
prefLabel
Insulin-like growth factor I r ...... man gastric cancer xenografts.
@ast
Insulin-like growth factor I r ...... man gastric cancer xenografts.
@en
P2093
P2860
P356
P1433
P1476
Insulin-like growth factor I r ...... uman gastric cancer xenografts
@en
P2093
D P Carbone
H Yamamoto
P2860
P304
P356
10.1136/GUT.2004.048926
P407
P577
2005-05-01T00:00:00Z